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INTRODUCTION
 The most common congenital heart defects in 
Down syndrome (DS) babies are atrioventricular 
septal defects (AVSD) and ventricular septal 
defects (VSD) with a prevalence of 54% and 40%, 
respectively.1 Numerous reports of association of 
inlet VSD with DS babies are also present as they 
are often found as a part of the AVSD complex.2 
These septal defects typically appear in the fetus 
or neonate and are a significant cause of cardiac 
morbidity and mortality in this age group, 
especially in complete atrioventricular septal 
defects (CAVSD).3
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ABSTRACT
Objective: To compare pre-operative, intra-operative, and post-operative parameters in Down syndrome 
(DS) and non-DS patients with atrioventricular septal defects (AVSD) and inlet ventricular septal defects 
(VSD) in a tertiary care hospital in Pakistan.
Methods: We conducted a retrospective study at Aga Khan University, Pakistan. All complete atrioventricular 
septal defect (CAVSD), partial atrioventricular septal defect (PAVSD), and VSD with inlet extension surgical 
cases from January 2007 to January 2019 were included. Patients with congenital heart diseases other than 
those listed above were excluded.
Results: In 61 cases, 18 had DS. Median age, mean body surface area (BSA), and height were lower 
in DS patients compared to non-DS patients: 7.0 vs 23.0 months, 0.311 vs 0.487 m2, and 63 vs 82 cm, 
respectively. Bypass duration, aortic cross clamp time, post-operative ventilator hours, dose of inotropes, 
CICU stay, and total hospital stay were all significantly higher in the DS group. The odds ratio (95% CI) 
for mortality in DS babies was 6.2 (1.4, 27.1), p=0.015, after adjusting for age, weight, and height. The 
overall morbidity was comparable between the two groups, demonstrating no significant difference after 
adjusting for confounders. 
Conclusion: DS babies with AVSD and inlet VSD are at a greater risk of mortality compared to non-DS 
babies, particularly those with CAVSD. Furthermore, DS babies undergo surgery at a younger age and 
require more aggressive post-operative therapy and monitoring due to the development of complications.
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 Over the years, there has been a decline in 
the mortality and reoperation rates among 
patients undergoing surgical treatment for AVSD 
indicating overall improved outcomes due to 
better surgical technique and perioperative care.4,5 
However, there are discrepancies in the clinical 
presentations and treatment outcomes of DS and 
non-DS patients with AVSD.  The early post-
operative morbidity rate among patients with 
DS and AVSD is higher while patients suffering 
from DS and CAVSD concurrently have a higher 
mortality risk compared to patients without 
these conditions.6 Considering the differences 
in various parameters among DS and non-DS 
patients with septal defects, it is important to 
assess and compare the pre-operative, intra-
operative, and post-operative parameters of the 
two groups in loco-regional settings.
METHODS
 We conducted a retrospective chart review 
at Aga Khan University Hospital, Karachi, 
Pakistan from January 2007 to January 2019 
and found 61 cases that satisfied our inclusion 
and exclusion criteria. All CAVSD, PAVSD, and 
VSD with inlet extension surgical cases were 
included. All other congenital heart diseases or 
concomitant congenital heart diseases (two or 
more pathologies) were excluded. When data 
sets were normally distributed, we used mean 
and standard deviation as the measurements of 
central tendency, and independent sample t-test 
for comparing means of continuous variables 
between discrete data for two groups and one-
way ANOVA test for more than two groups. In 
cases of non-normally distributed data, median 
and inter-quartile ranges were applied. For 
non-parametric data Mann Whitney U test and 
Kruskal Wallis test were applied. The chi-squared 
test was used for the comparison of qualitative 
data. A multivariate logistic regression model 
was built to adjust for confounders. A p-value 
<0.05 was considered significant. All statistical 
analysis was performed using SPSS version 20.0 
(IBM Corp., Armonk, N.Y., USA).
RESULTS
 Our study included 61 patients, of which there 
were 32 male and 29 female babies. Amongst this 
population, 30% patients had DS. Descriptive 
analysis shows that patients with DS underwent 
surgery at a younger age, and had a smaller body 
surface area and height (Table-I). Comparisons 
of the common presenting complaints among the 
groups are shown in Fig.1.
Table-I: Pre, intra, and post-operative parameters in Down and non-Down syndrome.
 With Down Without Down p-value
 Syndrome (n=18) Syndrome (n=43)
Gender, n (%)   0.381
     Male 11 (61%) 21 (49%) 
     Female 7 (39%) 22 (51%) 
Age at surgery, median (IQR), months 7 (5-19) 23 (5-78) 0.028
Weight, median (IQR), kg 6 (4-8) 9 (5-16) 0.067
Height, median (IQR), cm 63 (59-76) 82 (65-114) 0.011
Body surface area, median (IQR), 10-2m² 31.1 (26.7-41.9) 48.7 (29.5-77.7) 0.037
Bypass time, median (IQR), minutes 135 (95-185) 108 (80-130) 0.024
Aortic cross clamp time, mean (SD), min 105.3 (39.3) 77.5 (41.8) 0.019
Minimum temperature, mean (SD), °C 32.1 (1.6) 32.4 (1.9) 0.489
Mortality, n (%) 9 (50%) 4 (9%) 0.001
     CAVSD n (%) 8 (66.7%) 0 (0%) 
     VSD n (%) 1 (25%) 4 (23.5%) 
     PAVSD n (%) 0 (0%) 0 (0%) 
Re-opening, n (%) 2 (11%) 1 (2%) 0.205
Ventilator support, n (%) 17 (94%) 32 (74%) 0.089
Ventilation hours, median (IQR), hours 96.5 (45.3-202.8) 10.0 (2.0-36.0) <0.001
Inotrope administration, n (%) 17 (94) 35 (81) 0.259
Inotrope dose, median (IQR), mcg/kg/min 6.5 (1.0-16.3) 3.0 (0.0-5.0) 0.026
CICU stay, median (IQR), days 9 (5-16) 6 (3-8) 0.042
Total hospital stay, median (IQR), days 11 (8-22) 8 (7-15) 0.033
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 Intra-operatively, the bypass time and aortic 
cross clamp time were both significantly higher 
in the DS group (p<0.05). Post-operatively, the 
hours of ventilator support, the administered 
dose of inotropes, along with the total CICU 
and hospital stay were all significantly greater 
in DS patients (p<0.05). Some of the commonly 
observed post-operative morbidities included 
arrhythmia, pleural effusion, pneumothorax, 
pulmonary hypertension, and sepsis which 
were more common in DS than non-DS patients. 
Other morbidities, including pericardial effusion 
and chest infections, were more common in the 
non-DS group. Both pleural and pericardial 
effusions were managed conservatively as well 
as via chest tube insertion, while pneumothorax 
was primarily managed via tube thoracostomy. 
Patient characteristics for pre-, intra-, and post-
operative parameters in DS and non-DS patients 
are presented in Table-I.
 The most prevalent defect was CAVSD, 
followed by VSD and PAVSD. DS patients had a 
greater prevalence of CAVSD compared to non-
DS patients (67% vs. 38%), whereas VSD was 
comparable (22% vs. 24%) and PAVSD was higher 
in non-DS patients (11% vs. 24%).
 Overall operative mortality was 21.3%, however, 
DS had a greater number of deaths as compared to 
non-DS [n (%): 9 (50%) vs. 4 (9%)]. Furthermore, 
mortality was significantly associated with lower 
age (p<0.001), height (p=0.004), weight (p=0.002), 
and body surface area (p=0.002). The association 
of mortality and DS persisted after adjusting for 
age, height, and weight [(OR, 95% CI) 6.2 (1.4, 
27.1) p=0.015] (Table-II). Mortality rate of CAVSD 
patients in the DS group vs. non-DS group was 
66.7% vs. 0% (Table-I). Moreover, the patients 
that did not survive had spent a significantly 
greater number of hours on ventilator support 
(p=0.008). Common causes of mortality include 
cardiopulmonary arrest, sepsis, and arrhythmia.
 Post-operative ventilator use was associated 
with inotrope administration (p=0.001), 
specifically with higher doses of epinephrine 
(p=0.014) and milrinone (p=0.006) administered 
to patients on ventilator support. Patients on 
ventilator support also spent a significantly 
greater number of days in the CICU (p<0.001) 
and the hospital (p=0.002).
 Patients with CAVSD and VSD were younger at 
the time of surgery and had lower weight, height, 
and body surface area (p<0.001). Bypass and aortic 
cross clamp times were both highest in CAVSD 
patients and lowest in VSD patients (p<0.001), 
which suggests that CAVSD patients had more 
complex procedures. The minimum temperature 
during procedure was lowest in CAVSD patients 
and highest in VSD patients p=0.007 (Table-III).
DISCUSSION
 Congenital heart disease (CHD) is prevalent 
in 40% of patients with DS, and 0.3% in non-
DS.7,8 The surgical correction of CHD in these 
patients usually involves greater risk of post-
operative complications and mortality.9 Studies 
from Pakistan show that VSD and AVSD are the 
two most prevalent CHD in DS patients in the 
country (60.4% vs. 29.1%), however, we found 
that CAVSD has the greatest prevalence in DS 
patients followed by VSD (67% vs. 22%).10,11
 Repair of partial atrioventricular canal in Pakistan 
has good outcomes with minimal mortality. 
Moreover, early repair reduces post-operative 
morbidity and the cost of treatment.12,13 Most DS 
Major Septal Defects
Fig.1: Comparison (proportion) of presenting 
complaints in Down vs. non-Down 
syndrome patients.
Table-II: Univariate and multivariate logistic regression model for DS and non-DS.
Outcome variable Unadjusted Adjusted
  OR (95% CI) P value OR (95% CI) Adjusted* P value
Mortality  9.8 (2.6, 38.9) 0.001 6.2 (1.4, 27.1) 0.015
Morbidity¶  2.0 (0.6, 6.3) 0.236 1.4 (0.4, 4.8) 0.574
*Adjusted for age, weight and height; ¶Arrhythmia, respiratory infection, 
sepsis, pneumothorax, pleural and pericardial effusion, and pulmonary hypertension.
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patients in our study underwent repair at less than 
one year of age, which is consistent with other 
studies around the world.14 However, despite early 
repair, the presence of DS in patients significantly 
increases the risk of severe morbidities that have a 
significant impact on the recovery period, as well 
as on life expectancy even after successful CHD 
correction.15 Our study shows trends of increased 
morbidity in the DS group, however, it did not 
reach statistical significance possibly due to small 
sample size.
 The mortality rate in DS patients was significantly 
higher than non-DS patients, even after adjusting 
for confounders (age, weight, height). Within this 
mortality group, 61.5% of patients had a CAVSD. 
CAVSD is known to have poorer outcomes, longer 
median ventilation times, and intensive care unit 
and hospital stay (days), compared to other AVSD 
subtypes.3 Interestingly, we report no deaths in 
non-DS patients with CAVSD.
 Western literature suggests that there is no 
significant difference or lower risk of mortality after 
AVSD correction in DS patients, which contrasts 
our findings.6,16 This raises questions of possible 
differences in outcomes due to genetic, racial, 
environmental, and social factors which have not 
yet been explored in this region. This also highlights 
the need for developing indigenous guidelines for 
the management of these pathologies as currently 
practices from other countries (particularly from 
Western states) are being followed in Pakistan. 
Local guidelines were developed in India after the 
National Consensus Meeting on Management of 
Congenital Heart Diseases, 2018, which suggested 
that patients in the region are often underweight, 
malnourished, and have morbidities such as 
recurrent infections and anemia. Several patients 
present late with advanced level of pulmonary 
hypertension, ventricular dysfunction, hypoxia, 
and polycythemia. Therefore, the outcome after 
surgery in such patients has a greater possibility of 
being undesirable, justifying the need for revised 
guidelines and practices with a risk adjusted 
approach.17
 DS and non-DS patients have no significant 
differences in pre-operative hemodynamics, 
however, post-operative right heart pressures and 
pulmonary vascular resistances have remained 
significantly high in DS patients compared to 
non-DS patients.18 This could be a result of lung 
hypoplasia in DS patients, which predisposes them 
to pulmonary hypertension, leading to longer 
ventilation times and increased post-operative 
morbidity. An increased cross-clamp time, as seen 
in our DS patient group, is also directly correlated 
with increased ventilation support. Furthermore, 
DS patients in our study had a significantly higher 
cardiopulmonary bypass time (CBPT) and aortic 
cross-clamp time (XCT), with longest durations 
in the CAVSD group. Longer CBPT and XCT 
reflect more complex surgeries, indicating that DS 
and CAVSD patients underwent a more difficult 
repair.19 
Limitations of the study: The results of this study 
should be interpreted considering that this is a 
single center data analysis. Hence, reproducing 
the study on a larger scale, across multiple centers 
of the country, will yield more robust results. 
Since this study was conducted in one of the most 
urbanized areas of the country, socioeconomic 
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Table III: Pre-, intra- and post-operative parameters of all patients by the type of defect.
 CAVSD (n=28) PAVSD (n=12) VSD (n=21) p-value
Age at surgery, median (IQR), months 6.0 (10.5-66.8) 102.5 (60.0-156.0) 7.0 (4.0-18.5) <0.001
Weight, median (IQR), kg 6.0 (5.0-13.9) 20.5 (13.0-43.3) 5.0 (4.0-8.0) <0.001
Height, median (IQR), cm 67.5 (60.3-105.3) 123.5 (90.3-126.5) 102.5 (60.0-156.0) <0.001
Body surface area, median (IQR), m² 0.3 (0.3-0.7) 0.8 (0.6-1.3) 0.3 (0.2-0.4) <0.001
Bypass time, median (IQR), minutes 127.5 (116.0-150.0) 110.0 (92.5-150.0) 65.0 (50.0-106.0) <0.001
Aortic cross clamp time, mean (SD), minutes 108.1 (37.7) 97.2 (39.3) 49.4 (23.1) <0.001
Minimum temperature, mean (SD), °C 31.7 (1.8) 32.1 (1.2) 33.3 (1.8) 0.007
Mortality, n (%) 8 (29%) 0 (0%) 5 (24%) 0.122
Re-opening, n (%) 0 (0%) 1.0 (8.3%) 2.0 (10.0%) 0.259
Ventilator support, n (%) 22 (79%) 9 (75%) 18 (86%) 0.720
Ventilation hours, median (IQR), hours 29.0 (3.3-145.8) 4.0 (2.0-20.0) 20.5 (6.8-72.5) 0.160
Inotrope administration, n (%) 26 (93%) 9 (75%) 15 (71%) 0.273
Total hospital stay, median (IQR), days 9 (7-19) 7 (6-10) 10 (7-15) 0.343
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parameters in the sample population may not be 
an accurate representation of the population at 
large. Furthermore, only inpatient mortality has 
been listed but close follow-up on the patients 
could shed more light on outpatient and late 
mortality as well.
CONCLUSION
 DS babies with AVSD and inlet VSD are at a 
greater risk of mortality compared to non-DS babies, 
particularly those with CAVSD. Furthermore, 
DS babies undergo surgery at a younger age than 
non-DS babies and require more aggressive post-
operative therapy and monitoring due to the 
development of complications.
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